Probiodrug News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.08.16	Press Release: Probiodrug AG to Publish First Half 2016 Results on 30 August 2016 (Dow Jones)
23.08.16	DGAP-Vorabbekanntmachung: Probiodrug AG (EQS Group)
23.08.16	DGAP-Vorabbekanntmachung: Probiodrug AG (EQS Group)
12.08.16	Press Release: Probiodrug Announces Changes to the Supervisory Board and Executive Management (Dow Jones)
30.06.16	Press Release: Probiodrug and Crossbeta Biosciences enter into a strategic partnership in the field of Alzheimer's disease biomarkers (Dow Jones)
09.06.16	Press Release: Probiodrug:Two key patents on Glutaminyl Cyclase (QC) inhibition for the treatment of Alzheimer's disease (AD) granted in Japan (Dow Jones)
20.05.16	Press Release: Ordinary General Meeting of Shareholders of Probiodrug AG (Dow Jones)
12.05.16	Press Release: Probiodrug reports First Quarter -2- (Dow Jones)
12.05.16	Press Release: Probiodrug reports First Quarter 2016 Business Update (Dow Jones)
11.05.16	Press Release: Probiodrug to Present at the 1st Meeting of The Society for CSF analysis and Clinical Neurochemistry (Dow Jones)
04.05.16	Press Release: Probiodrug AG to Publish its First Quarter 2016 Business Update on May 12, 2016 (Dow Jones)
03.05.16	Press Release: Probiodrug to Attend and Present at European Conferences in May 2016 (Dow Jones)
28.04.16	DGAP-Stimmrechtsanteile: Probiodrug AG (EQS Group)
13.04.16	DGAP-Stimmrechtsanteile: Probiodrug AG Unitary 144A-Reg S (EQS Group)
13.04.16	DGAP-Stimmrechtsanteile: Probiodrug AG Unitary 144A-Reg S (EQS Group)
13.04.16	DGAP-Stimmrechtsanteile: Probiodrug AG Unitary 144A-Reg S (EQS Group)
13.04.16	DGAP-Stimmrechtsanteile: Probiodrug AG Unitary 144A-Reg S (EQS Group)
13.04.16	DGAP-Stimmrechte: Probiodrug AG (dpa-afx)
13.04.16	DGAP-Stimmrechte: Probiodrug AG (dpa-afx)
12.04.16	DGAP-Stimmrechtsanteile: Probiodrug AG Unitary 144A-Reg S (EQS Group)
12.04.16	DGAP-Stimmrechtsanteile: Probiodrug AG Unitary 144A-Reg S (EQS Group)
12.04.16	DGAP-Stimmrechte: Probiodrug AG (dpa-afx)
05.04.16	Press Release: Probiodrug to hold its Ordinary General Meeting of Shareholders on May 19, 2016 (Dow Jones)
04.04.16	Press Release: Probiodrug announces results of chronic toxicology studies with PQ912, its 'first in class' Glutaminyl Cyclase (QC) inhibitor for the treatmen... (Dow Jones)
23.03.16	Press Release: Probiodrug Appoints Mark Booth as Chief Business Officer (Dow Jones)
15.03.16	Press Release: Probiodrug Reports Full Year 2015 -3- (Dow Jones)
15.03.16	Press Release: Probiodrug Reports Full Year 2015 -2- (Dow Jones)
15.03.16	Press Release: Probiodrug Reports Full Year 2015 Financial Results (Dow Jones)
11.03.16	DGAP-Stimmrechtsanteile: Probiodrug AG Unitary 144A-Reg S (EQS Group)
11.03.16	DGAP-Stimmrechtsanteile: Probiodrug AG Unitary 144A-Reg S (EQS Group)
11.03.16	DGAP-Stimmrechte: Probiodrug AG (dpa-afx)
09.03.16	Press Release: Probiodrug's pGlu-Abeta Approaches being presented at 14th AAT Symposium on Advances in Alzheimer Therapy (Dow Jones)
07.03.16	Press Release: Probiodrug AG to Publish its Full Year 2015 Results on March 15, 2016 (Dow Jones)
07.03.16	DGAP-Vorabbekanntmachung: Probiodrug AG Unitary 144A-Reg S (EQS Group)
07.03.16	DGAP-Vorabbekanntmachung: Probiodrug AG Unitary 144A-Reg S (EQS Group)
30.11.15	DGAP-Gesamtstimmrechte: Probiodrug AG Unitary 144A-Reg S (EQS Group)
30.11.15	DGAP-Gesamtstimmrechte: Probiodrug AG Unitary 144A-Reg S (EQS Group)
30.11.15	DGAP-Kapitalmarktinformation: Probiodrug AG Unitary 144A-Reg S (EQS Group)
30.11.15	DGAP-Kapitalmarktinformation: Probiodrug AG Unitary 144A-Reg S (EQS Group)
30.11.15	DGAP-Gesamtstimmrechtsmitteilung: Probiodrug AG (dpa-afx)
12.11.15	DGAP-Vorabbekanntmachung: Probiodrug AG Unitary 144A-Reg S (EQS Group)
20.08.15	DGAP-Vorabbekanntmachung: Probiodrug AG Unitary 144A-Reg S (EQS Group)
08.05.15	DGAP-Stimmrechtsanteile: Probiodrug AG Unitary 144A-Reg S (EQS Group)
08.05.15	DGAP-Stimmrechtsanteile: Probiodrug AG Unitary 144A-Reg S (EQS Group)
08.05.15	DGAP-Stimmrechte: Probiodrug AG (dpa-afx)
08.05.15	DGAP-Stimmrechte: Probiodrug AG (dpa-afx)
06.05.15	DGAP-Vorabbekanntmachung: Probiodrug AG Unitary 144A-Reg S (EQS Group)
18.03.15	DGAP-Vorabbekanntmachung: Probiodrug AG Unitary 144A-Reg S (EQS Group)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Lonza Grp	606.00	1.41 %	K V
Logitech Intl	89.42	0.90 %	K V
Zurich Insur Gr	557.00	0.69 %	K V
ABB	49.35	0.65 %	K V
Swiss Re	139.30	0.32 %	K V
Novartis	95.59	-0.52 %	K V
Swisscom	506.00	-0.78 %	K V
Kuehne+Nagel Int	201.60	-0.79 %	K V
Sonova Hldg	305.20	-3.42 %	K V
UBS Group	29.55	-7.05 %	K V

Nachrichten zu Probiodrug AG

Aktien Top/Flop

Meistgelesene Nachrichten